Introduction {#s1}
============

Mitotic chromosome assembly, although poorly understood at the molecular level ([@bib35]), fulfils three major tasks essential for faithful chromosome segregation: First, it ensures chromosome compaction making cell division feasible within the cell space. Secondly, it provides chromosomes with the right mechanical properties (e.g. bendiness and rigidity) to facilitate their drastic movements during mitosis. Lastly, it ensures the resolution of the topological constrains that exist between the two sister DNA molecules, as well as between neighbouring chromosomes (chromosome individualization), a key requisite for efficient chromosome partitioning. At the heart of these structural changes are the condensin complexes. Condensin complexes, one of the most abundant non-histone complexes on mitotic chromosomes ([@bib9]; [@bib18]; [@bib32]), are composed of two structural maintenance of chromosome (SMC) proteins (SMC2 and SMC4) bridged by a kleisin subunit (Barren/Cap-H for condensin I and Barren2/Cap-H2 for condensin II)([@bib9]; [@bib18]; [@bib32]). Despite extensive research over the last years, how condensins contribute to chromosome morphology is not completely understood. Biochemical and phenotypic analysis of condensin depletion suggest several possible activities for these complexes, including the resolution of DNA entanglements ([@bib11]; [@bib15]; [@bib19]; [@bib21]; [@bib29]; [@bib37]; [@bib43]) and structural integrity by conferring chromosome rigidity ([@bib11]; [@bib20]; [@bib29]; [@bib37]). Whether or not these complexes also promote chromatin compaction remains controversial ([@bib15]; [@bib19]; [@bib18]; [@bib21]; [@bib23]; [@bib24]; [@bib29]; [@bib43]). The multiple phenotypes observed on mitotic chromosomes upon depletion of condensin complexes raise the possibility that these complexes may have distinct roles at different times of mitosis. Additionally, several lines of evidence support that these complexes also influence interphase chromosome structure ([@bib7]; [@bib16]). Thus, it is difficult, if not impossible to interpret the results when condensins are depleted prior to mitotic entry using conventional depletion approaches. To circumvent this limitation, we adopt a 'reverse and acute' approach to dissect the role of condensin I in the maintenance of chromosome organization. We find that inactivation of one condensin I specifically during metaphase leads to over-compaction at the majority of chromosomal regions. We further demonstrate that upon condensin I cleavage previously separated sister DNA molecules undergo topoisomerase II-dependent re-intertwining and complete failure in chromosome segregation.

Results {#s2}
=======

A TEV-protease mediated system to inactivate condensin I in *Drosophila melanogaster* {#s2-1}
-------------------------------------------------------------------------------------

To study the role of condensin complexes in the maintenance of chromosome structure, specifically during metaphase, we developed a system to enable analysis of chromosomal structural changes upon rapid and temporally controlled inactivation of condensin in *Drosophila melanogaster*. Our analysis focused on condensin I complex as prior studies reveal a minor role for condensin II in mitotic chromosome organization in *Drosophila* ([@bib16]; [@bib17]; [@bib39]). We developed a fast inactivation system to disrupt condensin I in the living fly ([Figure 1](#fig1){ref-type="fig"} and [Figure 1---figure supplement 1](#fig1s1){ref-type="fig"}), following a similar strategy previously used for the structurally related complex cohesin ([@bib31]; [@bib33]; [@bib45]). This system is based on the use of an exogenous protease (Tobacco Etch Virus, TEV) to cleave an engineered protein of interest that contains TEV-cleavage sites and allows specific, rapid and efficient protein inactivation in a tissue- and/or time-dependent manner ([Figure 1](#fig1){ref-type="fig"}, [Figure 1---figure supplement 1](#fig1s1){ref-type="fig"} and data not shown). To produce flies carrying solely TEV-sensitive condensin I complexes, we produced four versions of the kleisin subunit Barren that contain three consecutive TEV-cleavage sites at four different positions: aa175, aa389, aa437, aa600 ([Figure 1---figure supplement 1](#fig1s1){ref-type="fig"}). All versions are fully functional as they were able to complement the lethality associated with the Barren null allele *Barr^L305^* ([@bib3]) ([Figure 1---figure supplement 1b](#fig1s1){ref-type="fig"} and data not shown). In vitro cleavage experiments reveal that all modified proteins are efficiently cleaved by TEV protease ([Figure 1B](#fig1){ref-type="fig"} and [Figure 1---figure supplement 1](#fig1s1){ref-type="fig"}). The construct Barren^3xTEV175^-myc was chosen for future analysis based on the healthiness of the rescued strains (referred as Barren^TEV^ hereafter).10.7554/eLife.26120.003Figure 1.TEV-mediated cleavage of Barren disrupts condensin I function within a few minutes.(**a**) Schematic representation of condensin complex indicating the position of the 3xTEV cleavage sites in the kleisin subunit Barren (aa175). (**b**) In vitro cleavage of Barren^TEV^-myc. Extracts were prepared from ovaries of flies expressing solely TEV-cleavable Barren and incubated with TEV protease for the indicated time points (periods of time). The presence of full-length and cleaved Barren was monitored by western blot using myc antibodies. Tubulin was used as loading control. (**c**) Early embryos (0--30 min old) expressing HisH2AvD-mRFP1 (red) were injected with mRNA coding for Barren^TEV^-EGFP (green). Embryos were aged for 1 hr-1hr 30m to allow for protein expression. Embryos were injected with 12 mg/ml UbcH10^C114S^ protein to arrest in metaphase and subsequently with TEV-protease; images depict the same region before and after TEV injection; times (minutes:seconds) are relative to the time of injection; scale bar is 10 μm.**DOI:** [http://dx.doi.org/10.7554/eLife.26120.003](10.7554/eLife.26120.003)10.7554/eLife.26120.004Figure 1---figure supplement 1.A TEV-cleavable system to destroy condensin I.(**a**) graphic representation of the four positions used to introduce three consecutive TEV-protease consensus sites within the linker region of Drosophila Barren. Conservation with other species is shown and conserved regions are colour-coded. (**b**) Western blot analysis of the strain carrying solely Barren^175TEV^-myc, compared to wild-type strains, confirming the absence of endogenous protein. Extracts were prepared from ovaries and probed using the indicated antibodies. (**c--f**) Western blot analysis of in vitro cleavage of different versions of myc-tagged Barren^TEV^ or Rad21^TEV^. Extracts were prepared from ovaries of flies expressing TEV-cleavable Barren/Rad21 and incubated with TEV protease for the indicated time points. The presence of full-length and cleaved Barren was monitored by western blot using myc antibodies. Tubulin was used as loading control.**DOI:** [http://dx.doi.org/10.7554/eLife.26120.004](10.7554/eLife.26120.004)

TEV protease-mediated inactivation of condensin complexes has been previously successfully applied in yeast and mouse oocytes ([@bib10]; [@bib20]). However, in both cases the inactivation of condensin complexes took place within over an hour after TEV protease induction. Direct injection of TEV-protease into syncytial embryos, in contrast, allowed cleavage and the removal of chromosome-associated Barren^TEV^ within 8--15 min ([Figure 1b,c](#fig1){ref-type="fig"}), enabling the analysis of the immediate consequences upon disruption of this complex. To confirm that TEV-protease was able to inactivate condensin I efficiently within a few minutes, by cleavage of Barren^TEV^, we injected TEV protease in embryos derived from females surviving solely on Barren^TEV^ (ectopic expression of Barren^TEV^ in a *Barr^L305^* null background). Injection of TEV-protease in early interphase embryos leads to complete failure of the subsequent mitosis (which takes place within \~15 min in these embryos). Although chromosomes were able to condense upon nuclear envelope breakdown, centromeres, monitored by the Cenp-A ortholog Cid-EGFP, display significant stretching upon microtubule attachment ([Figure 2](#fig2){ref-type="fig"}, [Video 1](#media1){ref-type="other"} and [Video 2](#media2){ref-type="other"}). Moreover, resolution of sister chromatids is completely impaired, as chromatids appeared as a fused chromatin mass or display very thick bridges during the attempted anaphase ([Figure 2](#fig2){ref-type="fig"}, [Video 1](#media1){ref-type="other"} and [Video 2](#media2){ref-type="other"}). These results are in accordance with previous findings for condensin I depletion ([@bib11]; [@bib15]; [@bib19]; [@bib21]; [@bib29]; [@bib37]; [@bib43]), which ensures the developed system is efficient at promoting rapid condensin I inactivation.10.7554/eLife.26120.005Figure 2.Condensin I inactivation prior to mitotic entry.Embryos surviving solely on Barren^TEV^ were injected with buffer (**a**) or 13 mg/ml TEV protease (**b**) \~10--15 min before mitosis; Embryos also express His2A--mRFP1 (red) and Cid-EGFP (green); scale bars, 10 μm. Bottom rows show higher magnifications (\~3x) of a single nuclear division. Times (minutes:seconds) are relative to the time of anaphase onset.**DOI:** [http://dx.doi.org/10.7554/eLife.26120.005](10.7554/eLife.26120.005)Video 1.Mitosis in Drosophila embryos.Embryos were injected with buffer in early interphase and monitored throughout the subsequent mitosis. Embryos express HisH2Av-mRFP1 (red) and Cid-EGFP (green). Times are relative to injection time. Scale bar is 10 um.**DOI:** [http://dx.doi.org/10.7554/eLife.26120.006](10.7554/eLife.26120.006)10.7554/eLife.26120.006Video 2.Mitosis upon condensin I inactivation in Drosophila embryos.Embryos surviving solely on Barren^TEV^ were injected with TEV protease in early interphase and monitored in the subsequent mitosis. Embryos express HisH2Av-mRFP1 (red) and Cid-EGFP (green). Times are relative to injection time. Scale bar is 10 um.**DOI:** [http://dx.doi.org/10.7554/eLife.26120.007](10.7554/eLife.26120.007)10.7554/eLife.26120.007

Condensin I inactivation in metaphase leads to increased chromosome compaction {#s2-2}
------------------------------------------------------------------------------

To test the role of condensin I in the maintenance of chromosome architecture, we allowed mitotic chromosomes to assemble without any perturbation on their structure and subsequently disrupted condensin I during the metaphase-arrest. Embryos were arrested in metaphase, with a functional mitotic spindle, by the use of a catalytically dead dominant-negative form of the E2 ubiquitin ligase necessary for anaphase onset (UbcH10^C114S^)([@bib31]; [@bib36]). Arrested embryos were subsequently injected with TEV protease to destroy condensin I. Given the known role of condensin I in the rigidity of pericentromeric region of chromosomes ([@bib11]; [@bib29]; [@bib37]), we first tested the effect of TEV protease injection at those chromosomal sites. Whereas injection of buffer causes no change in the distance between centromeres, TEV protease injection in strains containing solely TEV-cleavable Barren results in rapid separation of centromeres, that appear to stretch towards the poles, leaving behind the majority of the chromatin mass ([Figure 3](#fig3){ref-type="fig"}, [Video 3](#media3){ref-type="other"} and [Video 4](#media4){ref-type="other"}). These findings imply that condensin I is not only required for the establishment of a rigid structure at the pericentromeric domains prior to metaphase, but also for the maintenance of such organization.10.7554/eLife.26120.008Figure 3.Condensin I inactivation in pre-assembled chromosomes leads to disruption of centromere structure and hyper-compaction of mitotic chromosomes.(**a**) Schematic representation of the experimental layout. Embryos expressing solely Barren^TEV^ were injected with 12 mg/ml of a dominant-negative form of the human E2 ubiquitin-conjugating enzyme (UbcH10^C114S^) to induce a metaphase arrest. Embryos were subsequently injected with buffer (**b**), 13 mg/ml TEV protease (**c**), 280 μM ICRF (**d**) or a mixture containing 13 mg/ml TEV protease and 280 μM ICRF (**e**); Images depict embryos before the second injection and 14 min after. Embryos also express His2A--mRFP1 (red) and Cid-EGFP (green); scale bars, 10 μm. Insets show higher magnifications (2.5x) of a single metaphase. Times (minutes:seconds) are relative to the time of the second injection. (**f**) Quantitative analysis of centromere positioning 10 min after the second injection, as above; graph shows average ± SEM of individual embryos (n ≥ 7 embryos for each experimental condition); for each embryo, a minimum of 8 metaphases was measured; (**g**) quantifications of mean voxel intensity, volume and surface area of the entire metaphase plate quantified in 3D, over time, and normalized to the time of the second injection. Graphs represent the average ± SEM of individual embryos (n ≥ 10 embryos for each experimental condition); for each embryo, a minimum of 8 metaphases was quantified.**DOI:** [http://dx.doi.org/10.7554/eLife.26120.008](10.7554/eLife.26120.008)10.7554/eLife.26120.009Figure 3---source data 1.Centromere displacement and chromosome compaction measurements upon condensin I and topoII inactivation.Individual measurements of centromeres displacement ([Figure 3f](#fig3){ref-type="fig"}) and relative Mean voxel intensity, relative volume and relative surface area ([Figure 3g](#fig3){ref-type="fig"}). Each data set is presented on a separate sheet.**DOI:** [http://dx.doi.org/10.7554/eLife.26120.009](10.7554/eLife.26120.009)10.7554/eLife.26120.010Figure 3---figure supplement 1.- Chromosome condensation induced by TEV-protease depends on TEV cleavage sites present in Barren^TEV^.(**a**) Representative images from embryos that do not contain TEV-cleavage sites in Barren. Embryos were injected with UbcH10^C114S^ to induce a metaphase arrest and subsequently injected with 13 mg/ml TEV protease. Embryos also express HisH2Av-RFP1 (red) and Cid-EGFP (green); scale bar is 10 μm. (**b**) Quantifications of mean voxel intensity, volume and surface area of the entire metaphase plate quantified in 3D, over time, and normalized to the time of the second injection. Graphs represent the average ± SEM of individual embryos (n ≥ 10 embryos for each experimental condition); for each embryo, a minimum of 8 metaphases was quantified.**DOI:** [http://dx.doi.org/10.7554/eLife.26120.010](10.7554/eLife.26120.010)Video 3.Buffer injection in metaphase-arrested embryos.Embryos expressing solely Barren^TEV^ were injected with 12 mg/ml of a dominant-negative form of the human E2 ubiquitin-conjugating enzyme (UbcH10^C114S^), to induce a metaphase arrest, and subsequently injected with buffer. Embryos also express His2A--mRFP1 (red) and Cid-EGFP (green); scale bars, 10 μm. Times (minutes:seconds) are relative to the time of buffer injection.**DOI:** [http://dx.doi.org/10.7554/eLife.26120.011](10.7554/eLife.26120.011)10.7554/eLife.26120.011Video 4.Condensin I inactivation in metaphase-arrested embryos.Embryos expressing solely Barren^TEV^ were injected with 12 mg/ml of a dominant-negative form of the human E2 ubiquitin-conjugating enzyme (UbcH10^C114S^), to induce a metaphase arrest, and subsequently injected with 13 mg/ml TEV protease. Embryos also express His2A--mRFP1 (red) and Cid-EGFP (green); scale bars, 10 μm. Times (minutes:seconds) are relative to the time of TEV injection.**DOI:** [http://dx.doi.org/10.7554/eLife.26120.012](10.7554/eLife.26120.012)10.7554/eLife.26120.012

Surprisingly, non-centromeric regions do not follow similar disorganization and in fact appeared to become more compacted. We defined chromosome compaction by degree of chromatin density, inferred from the signal of fluorescently labelled histone H2Av-mRFP1. To quantify the changes in chromosome compaction upon condensin inactivation, we used quantitative imaging analysis to monitor the mean voxel intensity, volume and surface area of each metaphase plate, over time, in 3D ([Figure 3d](#fig3){ref-type="fig"}). We found that injection of TEV protease in strains surviving only on Barren^TEV^ leads to an overall over-compaction of the entire chromatin mass, as evidenced by an increase in the mean voxel intensity and a decrease in both the surface area and the volume of the metaphase plate ([Figure 3c,d](#fig3){ref-type="fig"}). Injection of the protease in strains that do not contain TEV-cleavage sites does not result in any evident change in chromosome compaction relative to controls ([Figure 3---figure supplement 1](#fig3s1){ref-type="fig"}), implying that chromosome over-compaction is specific of condensin I inactivation.

In contrast, inactivation of Topoisomerase II (TopoII) using a small molecule inhibitor (ICRF-193), leads to rapid de-compaction of chromosomes ([Figure 3d,g](#fig3){ref-type="fig"} and [Video 5](#media5){ref-type="other"}). TopoII has been previously implicated in chromosome compaction although its role in the process remains controversial ([@bib35]). Although we cannot exclude that chromosome decompaction may be exacerbated by the fact that ICRF-193 traps TopoII onto chromatin, our results support that TopoII may contribute to chromosome compaction in metaphase, consistent with previous observations ([@bib38]), possibly by promoting self-entanglements within the same chromatid ([@bib22]). Importantly, combined inactivation of both TopoII and condensin I results in chromosome decompaction similar to TopoII inhibition alone ([Figure 3e,g](#fig3){ref-type="fig"} and [Video 6](#media6){ref-type="other"}). This finding implies that chromatin hyper-compaction observed upon loss of condensin I depends on TopoII activity.Video 5.Topoisomerase II inhibition in metaphase-arrested embryos.Embryos expressing solely Barren^TEV^ were injected with 12 mg/ml of a dominant-negative form of the human E2 ubiquitin-conjugating enzyme (UbcH10^C114S^), to induce a metaphase arrest, and subsequently injected with 280 μM ICRF-193. Embryos also express His2A--mRFP1 (red) and Cid-EGFP (green); scale bars, 10 μm. Times (minutes:seconds) are relative to the time of ICRF injection.**DOI:** [http://dx.doi.org/10.7554/eLife.26120.013](10.7554/eLife.26120.013)10.7554/eLife.26120.013Video 6.Concomitant inactivation of Topoisomerase II and Condenin I in metaphase-arrested embryos.Embryos expressing solely Barren^TEV^ were injected with 12 mg/ml of a dominant-negative form of the human E2 ubiquitin-conjugating enzyme (UbcH10^C114S^), to induce a metaphase arrest, and subsequently injected with a mix of 280 μM ICRF-193 and 13 mg/ml TEV protease. Embryos also express His2A--mRFP1 (red) and Cid-EGFP (green); scale bars, 10 μm. Times (minutes:seconds) are relative to the time of the second injection.**DOI:** [http://dx.doi.org/10.7554/eLife.26120.014](10.7554/eLife.26120.014)10.7554/eLife.26120.014

Condensin I inactivation results in de novo sister chromatid intertwines {#s2-3}
------------------------------------------------------------------------

The unexpected finding that condensin I inactivation promotes further chromosome compaction, together with the observation that TopoII inhibition reverts this hyper-compaction phenotype, lead us to hypothesize that the observed increase in compaction stems from re-entanglements of DNA strands, which would consequently lead to an increase in chromatin density. Enzymatically, TopoII can promote both the decatenation and the concatenation of DNA strands. Efficient chromosome segregation requires that TopoII is strongly biased towards decatenation prior to anaphase onset but it is conceivable that TopoII can additionally drive the concatenation of native metaphase chromosomes, in vivo. To test whether condensin I removal leads to re-catenation of previously separated sisters, we tested several predictions that arise from this hypothesis: First, the hyper-compaction observed in metaphase, if derived from sister-chromatid re-intertwining, should be dependent on the proximity between DNA molecules. The physical separation of sister chromatids will increase the distance between these two molecules, placing them too far apart, and consequently decreasing the likelihood of their re-entanglement, as recently proposed ([@bib42]). Secondly, re-intertwining in late metaphase should lead to severe segregation failures. And lastly, DNA entanglements and the consequent segregation defects should depend on TopoII activity.

To evaluate the effect of sister chromatid proximity in chromosome condensation upon condensin inactivation we combined TEV-mediated cleavage of condensin I and cohesin by the use of strains carrying TEV-sensitive Rad21 (cohesin) and Barren (condensin) proteins. We took advantage of the fact that Rad21^TEV^ cleavage is more efficient than Barren^TEV^ ([Figure 1---figure supplement 1](#fig1s1){ref-type="fig"}), which allowed the analysis of changes in chromosome architecture upon condensin inactivation after artificial separation of sister chromatids. Upon TEV protease injection, pole-ward chromosome segregation is initiated within 2 to 5 min and with similar kinetics in both strains ([Figure 4a](#fig4){ref-type="fig"}).10.7554/eLife.26120.015Figure 4.Condensin I inactivation in separated sister chromatids reduces their movement.(**a**) Representative images of the initial separation after TEV-mediated cleavage of Rad21^TEV^ and Rad21^TEV^ + Barren^TEV^. Graph plots the relative distribution of HisH2B-RFP at the maximal state of sister chromatid separation triggered by TEV-mediated cleavage of Rad21^TEV^, in strains that contain solely Rad21^TEV^ or both Rad21TEV and Barren^TEV^. A 15 μm line was used to measure plot profiles along the segregation plane, measured 3--5 min after TEV protease injection. Graphs plot the average ± SEM of individual embryos (n ≥ 7 embryos for each experimental condition). For each embryo, between 8 and 12 anaphases were analysed. (**b**) Example of chromosome movement analysis; left panel represents average of the binary images of three consecutive frames, used to estimate chromosome displacements: blue, non-overlapping pixels; green, two- out of three-frame overlap; grey, three-frame overlap. Scale bar is 10 μm. (**c**) Frequency of overlapping pixels to estimate chromosome displacement (as in b), over time, after TEV protease injection.**DOI:** [http://dx.doi.org/10.7554/eLife.26120.015](10.7554/eLife.26120.015)10.7554/eLife.26120.016Figure 4---source data 1.Measurements of segregation efficiency and chromosome movement upon cohesin/condensin inactivation.Individual measurements of segregation efficiency ([Figure 4a](#fig4){ref-type="fig"}) and chromosome displacement ([Figure 4c](#fig4){ref-type="fig"}.) Each data set is presented on a separate sheet.**DOI:** [http://dx.doi.org/10.7554/eLife.26120.016](10.7554/eLife.26120.016)

After the initial pole-ward chromatid movement, isolated chromatids shuffle between the poles, consistent with previous observations ([@bib31]). To quantify the degree of movement, we used a displacement-quantification method that infers chromosome movement by the overlap between chromosome positions on consecutive frames ([@bib27]). Cohesin cleavage alone leads to strong shuffling of isolated single chromatids, as previously described. However, concomitant inactivation of condensin and cohesin results in much slower chromatid movements, with chromatids accumulating in the middle of the segregation plane ([Figure 4b,c](#fig4){ref-type="fig"}). Condensin I is thus important for efficient movement of isolated chromatids. This may be due abnormal centromere/kinetochore structure and/or to a possible role for condensin in the error-correction process, as recently proposed ([@bib34]; [@bib46]).

The reduced chromosome movement observed upon condensin I inactivation leads to considerable differences in chromatid positioning in both experimental set-ups. Thus, we restricted our chromosome morphology/compaction analysis to measurements of isolated single sisters, as quantifying the entire chromatin mass would include many confounding variables. Measurements of isolated single chromatids were performed at 20 min after injections and normalized to the values at 5 min after protease injection (once complete separation has occurred but no significant changes in chromosome structure was yet observed). Chromatids considerably change their shape, becoming thicker and shorter ([Figure 5b,c](#fig5){ref-type="fig"}, [Video 7](#media7){ref-type="other"} and [Video 8](#media8){ref-type="other"}), as previously described ([@bib13]; [@bib32]). To directly measure the degree of compaction of these isolated sisters, we measured their mean voxel intensity. This analysis revealed that despite the significant changes in chromatid organization, there is no overall change in the mean voxel intensity of single chromatids ([Figure 5d](#fig5){ref-type="fig"}), indicating that shape changes are not accompanied by an overall increase in chromatin compaction. We therefore conclude that condensin I inactivation does not promote further chromosome compaction if sister chromatids are physically apart, in contrast to the effect observed in metaphase-arrested chromosomes ([Figure 3](#fig3){ref-type="fig"}). These results support that over-compaction observed in metaphase chromosomes may arise from sister chromatid re-intertwining, consistent with previous observations using yeast circular mini-chromosomes ([@bib42]). It is conceivable that condensin I inactivation also promotes abnormal re-entanglement in cis (between distal regions of the same chromatid). The shape changes observed upon condensin inactivation from isolated sisters (shorter and thicker chromatids) could indeed be explained by an excess of concatenation within the same DNA molecule, leading to the shortening of the longitudinal axis. However, our compaction measurements indicate that such changes, if occur, do not lead to detectable increase in chromatin density.10.7554/eLife.26120.017Figure 5.Chromosome over-compaction depends on sister-chromatid proximity.(**a**) Stills from metaphase-arrested embryos after injection of TEV protease in strains surviving solely on Rad21^TEV^ (cohesin cleavage) or Rad21^TEV^+Barren^TEV^ (cohesin and condensin cleavage); embryos also express HisH2B-RFP; scale bars, 5 μm. Insets show higher magnifications (3x) of single chromatids 20 min after TEV injection. Times (minutes:seconds) are relative to the time of TEV injection. (**b--c**) Relative frequency of sister chromatid length (**b**) and width (**c**) at 20 min after TEV injections (n ≥ 120 single chromatids from seven independent embryos for each experimental condition). (**d**) Mean voxel intensity of isolated single chromatids 20 min after TEV injections, normalized to mean voxel intensity 5 min past injection. (n ≥ 10 embryos for each experimental condition).**DOI:** [http://dx.doi.org/10.7554/eLife.26120.017](10.7554/eLife.26120.017)10.7554/eLife.26120.018Figure 5---source data 1.Measurements of isolated chromatids upon cohesin/condensin inactivation.Individual measurements of chromosome thickness, length and mean voxel intensity upon TEV-mediated cleavage of Read21^TEV^ and Rad21TEV+Barren^TEV^. Each data set is presented on a separate sheet. File includes descriptive statistics.**DOI:** [http://dx.doi.org/10.7554/eLife.26120.018](10.7554/eLife.26120.018)Video 7.Artificial induction of sister chromatid separation in metaphase-arrested embryos.Embryos expressing solely Rad21^TEV^ and wild-type Barren were injected with 12 mg/ml of a dominant-negative form of the human E2 ubiquitin-conjugating enzyme (UbcH10^C114S^), to induce a metaphase arrest, and subsequently injected with 13 mg/ml TEV protease. Embryos also express His2B--RFP; scale bars, 10 μm. Times (minutes:seconds) are relative to the time of the second injection.**DOI:** [http://dx.doi.org/10.7554/eLife.26120.019](10.7554/eLife.26120.019)10.7554/eLife.26120.019Video 8.Effect of condensin I inactivation on isolated sister chromatids.Embryos expressing uniquely TEV-sensitive Rad21 and Barren were injected with 12 mg/ml of a dominant-negative form of the human E2 ubiquitin-conjugating enzyme (UbcH10^C114S^), to induce a metaphase arrest, and subsequently injected with 13 mg/ml TEV protease. Embryos also express His2B--RFP; scale bars, 10 μm. Times (minutes:seconds) are relative to the time of the second injection.**DOI:** [http://dx.doi.org/10.7554/eLife.26120.020](10.7554/eLife.26120.020)10.7554/eLife.26120.020

Next, we sought to evaluate chromosome segregation defects, which serve as an indirect read-out for the amount of DNA catenations bridging DNA molecules. To monitor segregation defects when condensin I or TopoII are inactivated specifically in metaphase, we developed conditions in which unperturbed chromosomes would be transiently arrested in metaphase by the dominant negative UbcH10^C114S^, for \~3--5 min, and subsequently injected with the respective perturbing factor in metaphase. Embryos were subsequently injected with a wild-type version of UbcH10 14 min later, which causes anaphase onset and mitotic exit in about 4--8 min ([Figure 6a](#fig6){ref-type="fig"}). We monitored the segregation efficiency during anaphase by quantitative analysis of the profile of Histone H2AvD-mRFP (to visualize chromatin separation) and Cid-EGFP (to infer centromere segregation) along the segregation plane ([Figure 6](#fig6){ref-type="fig"}). In this assay, injection of buffer causes virtually no defects in the segregation of sister chromatids ([Figure 6b](#fig6){ref-type="fig"}, [Figure 6---figure supplement 1](#fig6s1){ref-type="fig"} and [Video 9](#media9){ref-type="other"}).10.7554/eLife.26120.021Figure 6.Condensin I inactivation results in TopoII-dependent sister chromatids intertwines and segregation failure.(**a**) Schematic representation of the experimental set-up. Embryos were arrested with 12 mg/ml UbcH10^C114S^ and injected with buffer (**b**), 280 μM ICRF-193 (**c**), 13 mg/ml TEV protease (**d**) or TEV+ICRF-193, while in metaphase; Embryos were subsequently injected with 14 mg/ml of a wild-type version of UbcH10 to release them from the arrest. Images depict representative images of the anaphase; Graphs plot the relative distribution of HisH2Av-mRFP1 and Cid-EGFP across the 15 μm segregation plane, measured 4--6 min after anaphase onset. Graphs plot the average +\_SEM of individual embryos (n ≥ 10 embryos for each experimental condition). For each embryo, at least eight anaphases were analysed. (**f**) Quantification of centromere distances during UbcH10^wt^-induced anaphase as in (**b--e**). Graphs plot the distances between segregating centromeres measured 6 min after anaphase onset (n ≥ 10 embryos for each experimental condition; for each embryo, at least eight anaphases were analysed). Statistical analysis was performed using the non-parametric Kruskal-Wallis test; ns p\>0.05, \*p\<0.05; \*\*\*p\<0.001.**DOI:** [http://dx.doi.org/10.7554/eLife.26120.021](10.7554/eLife.26120.021)10.7554/eLife.26120.022Figure 6---source data 1.Measurements of segregation efficiency after metaphase-specific inactivation of condensin and/or Topoisomerase II.Anaphase profiles for HisH2Av-mRFP1 and Cid-EGFP measured 4--6 min after anaphase onset ([Figure 6b-2](#fig6){ref-type="fig"}). Each measurement represents the average for independent embryos (resulting from at least eight anaphases measured). Individual sheets include either the same measurement for the four experimental conditions or both Cid-EGFP and HisH2Av-mRFP1 for the same experiment, as indicated. Centromere separation measurements ([Figure 6f](#fig6){ref-type="fig"}) also include descriptive statistics.**DOI:** [http://dx.doi.org/10.7554/eLife.26120.022](10.7554/eLife.26120.022)10.7554/eLife.26120.023Figure 6---figure supplement 1.-- Comparative analysis of segregation efficiency for condensin and/TopoII inhibition before mitosis (light colour) and during metaphase arrest/release (dark colour); Graphs plot the relative distribution of HisH2Av-mRFP1 (red) and Cid-EGFP (green) across a 20 μm segregation plane, measured 4--6 min after anaphase onset.Graphs plot the average +\_SEM of individual embryos (n ≥ 8 embryos for each experimental condition). For each embryo, at least eight anaphases were analysed.**DOI:** [http://dx.doi.org/10.7554/eLife.26120.023](10.7554/eLife.26120.023)Video 9.Induced anaphase in control embryos.Embryos expressing solely Barren^TEV^ were injected with 12 mg/ml of a dominant-negative form of the human E2 ubiquitin-conjugating enzyme (UbcH10^C114S^), to induce a metaphase arrest, and subsequently injected with buffer. After 14 min embryos were injected a wild-type version of UbcH10 to induce anaphase. Embryos also express His2A--mRFP1 (red) and Cid-EGFP (green); scale bars, 10 μm.**DOI:** [http://dx.doi.org/10.7554/eLife.26120.024](10.7554/eLife.26120.024)10.7554/eLife.26120.024

Inactivation of TopoII under these conditions leads mostly to the appearance of fine chromatid bridges ([Figure 6c](#fig6){ref-type="fig"} and [Video 10](#media10){ref-type="other"}). These residual bridges are insufficient to delay centromere separation (11,01 ± 2,03 μm upon ICRF-193 treatment compared to 10,72 ± 1,69 μm in buffer-injected embryos; [Figure 6f](#fig6){ref-type="fig"}). The extent of chromatin bridges observed upon metaphase-specific inactivation of TopoII is considerably lower when compared to experiments where this enzyme is inhibited prior to mitotic entry ([Figure 6---figure supplement 1](#fig6s1){ref-type="fig"}). These findings imply that in metaphase-arrested chromosomes the amount of unresolved catenations is residual. In contrast, inactivation of condensin I during metaphase leads to complete impairment of the segregation process, as revealed by the high frequency of 'fused' chromatin masses, with the chromosomes remaining in the centre of the segregation plane, and a significant decrease in the distance between segregating centromeres (6,08 ± 0,92 μm) ([Figure 6d,f](#fig6){ref-type="fig"} and [Video 11](#media11){ref-type="other"}). The degree of segregation defects observed in these metaphase-inactivation experiments, is even higher than the defects observed upon condensin inactivation prior to mitotic entry ([Figure 6---figure supplement 1](#fig6s1){ref-type="fig"}). The severity of segregation impairment upon metaphase-specific condensin I inactivation indicates that in the absence of this complex previously resolved sister DNA molecules undergo re-catenation.Video 10.Induced anaphase after timely inhibition of topoisomerase II.Embryos expressing solely Barren^TEV^ were injected with 12 mg/ml of a dominant-negative form of the human E2 ubiquitin-conjugating enzyme (UbcH10^C114S^), to induce a metaphase arrest, and subsequently injected with 280 μM ICRF-193. After 14 min embryos were injected a wild-type version of UbcH10 to induce anaphase. Embryos also express His2A--mRFP1 (red) and Cid-EGFP (green); scale bars, 10 μm.**DOI:** [http://dx.doi.org/10.7554/eLife.26120.025](10.7554/eLife.26120.025)10.7554/eLife.26120.025Video 11.Induced anaphase after timely inhibition of Condensin I.Embryos expressing solely Barren^TEV^ were injected with 12 mg/ml of a dominant-negative form of the human E2 ubiquitin-conjugating enzyme (UbcH10^C114S^), to induce a metaphase arrest, and subsequently injected with 13 mg/ml TEV protease. After 14 min embryos were injected a wild-type version of UbcH10 to induce anaphase. Embryos also express His2A--mRFP1 (red) and Cid-EGFP (green); scale bars, 10 μm.**DOI:** [http://dx.doi.org/10.7554/eLife.26120.026](10.7554/eLife.26120.026)10.7554/eLife.26120.026

To directly test this hypothesis, we accessed whether or not de novo chromatin intertwines take place upon condensin inactivation, as the formation of these new links should depend on TopoII activity. If TopoII-dependent re-catenation occurs upon condensin I inactivation, one would expect that the combination of TopoII and condensin I inactivation should reduce the amount of chromatin trapped in the middle of the segregation plane. On the contrary, if segregation defects result from pre-existing catenations, combined inhibition of condensin I and TopoII should increase, or at least maintain, the density of chromosome bridges and segregation impairment.

To address this issue, we used the same experimental layout as above but induced concomitant inactivation of condensin I and TopoII during the metaphase arrest. These experiments reveal a partial rescue of the retained chromatin mass, inferred by HisH2Av-mRFP1 profile ([Figure 6e](#fig6){ref-type="fig"} and [Video 12](#media12){ref-type="other"}). Chromosome positioning may not be linearly correlated with the amount of linkages bridging the two sister chromatids and thus the reduction on chromosome intertwines may be even more pronounced than inferred by histone profiles. In accordance with this notion, the efficiency of chromosome separation inferred by the position of centromeres returns to levels indistinguishable from wild-type ([Figure 6e,f](#fig6){ref-type="fig"} and [Video 12](#media12){ref-type="other"}). Thus, concomitant inactivation of condensin I and TopoII significantly reverts the defects associated with condensin I removal. We therefore conclude that the segregation defects observed upon metaphase-specific condensin I inactivation are caused by de novo TopoII-dependent re-intertwining of previously separated sister chromatids.Video 12.Induced anaphase after timely inhibition of Condensin I and topoisomerase II.Embryos expressing solely Barren^TEV^ were injected with 12 mg/ml of a dominant-negative form of the human E2 ubiquitin-conjugating enzyme (UbcH10^C114S^), to induce a metaphase arrest, and subsequently injected with a mix of 280 μM ICRF-193 and 13 mg/ml TEV protease. After 14 min embryos were injected a wild-type version of UbcH10 to induce anaphase. Embryos also express His2A--mRFP1 (red) and Cid-EGFP (green); scale bars, 10 μm.**DOI:** [http://dx.doi.org/10.7554/eLife.26120.027](10.7554/eLife.26120.027)10.7554/eLife.26120.027

Discussion {#s3}
==========

The role of condensin complexes in chromosome compaction has been extensively debated. Here we provide evidence that temporally controlled inactivation of condensin I, specifically during metaphase, causes an increase in the overall levels of chromosome compaction in non-centromeric regions. These findings strongly argue that condensin I is required to maintain chromosomal architecture but not to sustain their compacted state. Studies using similar inactivation techniques in mouse oocytes have proposed that condensins confirm longitudinal rigidity, as chromosomes disassemble upon condensin inactivation (particularly condensin II)([@bib20]). At first sight, these findings may be perceived as in sharp contrast to our current observations. It should nevertheless be noted that meiotic chromosomes are under very different force-balance than their mitotic counterparts. In particular, spindle attachment on meiotic bivalents imposes stretching along the longitudinal axis of chromosomes, similarly to what we report here for the pericentromeric region in mitotic chromosomes. Our results now demonstrate that when chromosomes are not subjected to significant additional forces, condensin I inactivation results in an overall chromatin over-compaction rather than chromosome de-condensation. This force-dependent phenotype may explain several inconsistencies in prior analysis on condensins depletion that as sample preparation, chromosome state, presence/absence of microtubules, or even the cell division type (mitosis vs meiosis) may play a major role in chromosome morphology. In contrast to condensin I inactivation, TopoII inhibition leads to rapid chromosome decompaction. These finding are consistent with the idea that metaphase chromosome structure is organized as a chromatin network resultant from self-entanglements of DNA strands, as initially proposed by biophysical studies on isolated chromosomes ([@bib22]). Restricting/favouring chromosome entanglements may thus dictate the state of chromosome compaction.

Condensin has been previously proposed to interplay with TopoII, both for chromosome compaction and sister chromatid resolution. The exact details for this interaction, however, remain elusive. Both condensins and TopoII inactivation impair sister chromatid resolution ([@bib3]; [@bib6]; [@bib11]; [@bib15]; [@bib19]; [@bib21]; [@bib29]; [@bib37]; [@bib43]; [@bib44]), suggesting these two molecules have cooperative roles on chromosome resolution. In contrast, cytological analyses suggest that condensin and TopoII have opposite roles in shaping mitotic chromatin ([@bib38]), raising further doubts on their functional interaction. It has long been hypothesized that condensin may impose directionality on TopoII reactions ([@bib1]; [@bib4]; [@bib8]; [@bib25]), as this enzyme is able to both decatenate and catenate DNA strands. But this model has been very difficult to formally prove. Studies in yeast using artificial circular mini-chromosomes, in which the levels of catenation can be directly measured, support that full decatenation by TopoII requires condensin activity ([@bib2]; [@bib1]; [@bib4]). Whether the same is true in large and linear native chromosomes remained to be addressed, particularly as circular chromosomes are under different topological constrains when compared to linear ones. The experimental approach used in our study allowed the manipulation of native chromosomes, in their natural environment, providing evidence that upon removal of condensin I, previously separated sister chromatids re-intertwine in a TopoII-dependent manner. These findings are in agreement with a recent study that revealed that the resolution of sister chromatids from circular minichromosomes can be reverted by increased expression of TopoII ([@bib42]). All together, these results support that condensin I is not directly necessary for TopoII catalytic activity, but rather to impose directionality on TopoII reactions, favouring resolution of the sister DNA molecules rather than their intertwine. Upon condensin I removal, creation of new links between previously separated DNA strands leads to their increased proximity, which may underlie the observed increase in chromosome compaction. Importantly, our studies reveal that TopoII is able to promote erroneous re-entanglements of sister chromatids throughout mitosis, an activity that needs to be constantly opposed by condensin I.

How condensin I is able to confer such directionality remains to be addressed. Condensins are enriched at the chromosome axis where they have been proposed to promote interactions within the same chromatid ([@bib32]; [@bib43]). Condensin I was shown to display significant turn-over on mitotic chromosomes ([@bib11]; [@bib30]) highlighting that its mode of action relies in dynamic reactions rather than statically holding chromatin loops. Bringing strands of DNA from the same chromatid in close proximity could alone favour sister chromatid decatenation by limiting the probability contacts between sister DNA molecules. Models that predict that DNA loops can extrude away from condensin have been hypothesized ([@bib12]; [@bib28]) and are better at explaining the directionally issue, as they provide a mechanism that inherently explains how condensins distinguish intra- versus inter-chromosomal looping. Random intrachromatid linkages are also possible ([@bib5]; [@bib10]), although in this case additional mechanisms may ensure that connections in cis are favoured over linkages between sister- (and nearby) chromatids. Condensin I- mediated supercoiling of the DNA molecule has also been proposed to change DNA structure to favour DNA decatenation activity ([@bib2]; [@bib1]; [@bib42]), although it is yet to be determined whether the supercoiling activity of this complex can account for all the phenotypes associated with condensin loss.

Our analysis further reveals that maintenance of chromosome architecture, particularly sister chromatid resolution, is not a unidirectional process but instead a much more dynamic reaction than previously anticipated. It is conceivable that the highly compacted chromatin state present in metaphase chromosomes could, on its own, shift TopoII reaction towards sister chromatid re-entanglement given the increased proximity between DNA strands. Condensin I would thus counteract an inherent tendency of chromosomes to re-intertwine, a reaction necessary throughout metaphase. Additionally, it is possible that a dynamic balance of chromosome entanglements allows remodelling of chromosome architecture, providing chromosomes with plasticity to counteract the cytoplasmic drag faced during dynamic movements. Energy released during these reactions could potentially be used to further facilitate chromosome movement. Mitotic chromosomes should thus be visualized as highly dynamic structures during mitosis, whose re-shaping may be fundamental for the fidelity of their own segregation.

Materials and methods {#s4}
=====================

Fly strains {#s4-1}
-----------

To destroy condensin by TEV protease-mediated cleavage, strains carrying solely TEV-sensitive Barren versions were produced. A construct carrying a \~4.7 kb Barren genomic region was used as a starting point (kindly provided by Beat Suter, Institute of Cell Biology, University of Bern). This region contains the regulatory sequences and was previously shown to restore Barren function ([@bib26]). This construct was engineered to add a 10xMyc sequence at the C-terminus of Barren. Three consecutive TEV recognition sites were placed at different positions (corresponding to a.a. 175, a.a. 389, a.a. 437 and a.a 600). Cloning details are available upon request. Each variant of genomic Barren with different TEV sites was cloned into pCaSpeR4 vector used for fly transformation. Transgenic flies were produced by P-element integration (BestGene Inc, Chino Hills, CA). Transgenes were placed in a *Barr^L305^* background, a Barren null allele ([@bib3]), over a deficiency for the corresponding genomic region (*Df(2L)Exel7077*, stock \#7850 from Bloomington stock center). To destroy cohesin by TEV-protease we used strains carrying Rad21^TEV^, previously described ([@bib31]; [@bib33]). Fly strains also expressed His2AvD--mRFP1 or polyubiquitin His2B--RFP, to monitor DNA and EGFP--Cid to monitor centromeres ([@bib41]). A list with detailed genotypes can be found in [Table 1](#tbl1){ref-type="table"}.10.7554/eLife.26120.028Table 1.List of fly strains used in this study**DOI:** [http://dx.doi.org/10.7554/eLife.26120.028](10.7554/eLife.26120.028)CHR\#^\*^GenotypeReference1418*Barr^L305^/CyO*[@bib3]\
(RRID:[BDSC_4402](https://scicrunch.org/resolver/BDSC_4402))1421*Df(2L)Exel7077/CyO*Blommington \#7850\
(RRID:[BDSC_7850](https://scicrunch.org/resolver/BDSC_7850))1513*w;; Barr(175 - 3TEV)-myc10 III.5*This study1509*w; Barr(175 - 3TEV)-myc10 II.1;*This study1522*w;; Barr(389 - 3TEV)-myc10 III.2*This study1514*w;; Barr(437 - 3TEV)-myc10 III.1*This study1520*w;; Barr(600 - 3TEV)-myc10 III.3*This study1525*w;; Barr(wt)-myc10 III.1*This study1560*w; Barr^L305^/ Df(2L)Exel7077; Barr(175 - 3TEV)-myc10 III.5*This study820*w;; HisH2AvD-mRFP1 III.1, CGC (CID-EGFP) III.1*[@bib41]1564*Df(2L)Exel7077 / CyO; HisH2AvD-mRFP1 III.1, CGC (CID-EGFP) III.1*This study*w; Barr^L305^/ Df(2L)Exel7077; Barr(175 - 3TEV)-myc10 III.5/ HisH2AvD-mRFP1 III.1, CGC (CID-EGFP) III.1*\
629*w;; Rad21^ex15^, polyubiq-H2B-RFP, tubpr-Rad21(550-3TEV) -myc10*[@bib31]1646*w; Barr^L305^, Barr(175 - 3TEV)-myc10 II.1; +/+*This study1648*w; Barr^L305^, Barr(175 - 3TEV)-myc10 II.1; Rad21^ex15^, polyubiq-H2B-RFP, tubpr-Rad21(550-3TEV) -myc10*This study[^1]

Microinjections {#s4-2}
---------------

Microinjection experiments were performed as previously described ([@bib31]). 1--1.5 hr old embryos (or 0--30 min for mRNA injections) were collected and processed according to standard protocols, and embryos were injected at the posterior pole (up to three sequential injections) using a Burleigh Thorlabs Micromanipulator, a Femtojet microinjection system (Eppendorf, Germany), and pre-pulled Femtotip I needles (Eppendorf). Embryos were injected with buffer, drugs or proteins purified from *E. coli* at the following concentrations: Buffer (20 mM Tris-HCl at pH 8.0, 1 mM EDTA, 50 mM NaCl and 2 mM DTT), 13 mg/ml TEV protease in TEV buffer, 12 mg/ml UbcH10^C114S^, 14 mg/ml UbcH10^wt^ and/or 280 μM ICRF-193 (Sigma-Aldrich, St Louis, MO).

Protein purification {#s4-3}
--------------------

Purified TEV protease was described previously ([@bib14]). Purification of UbcH10^wt^ and UbcH10^C114S^ was performed from BL21 cells as previously described ([@bib31]), with minor modifications, as follows. Bacterial cells were grown for 16 hr at 37°C, 225 rpm. This pre-culture was used to inoculate fresh LB media and cells were allowed to grow until 0.8/1 ODs. Cultures were then induced with 1 mM IPTG and after 4 hr of induction at 37°C, 225 rpm, cells were harvested. Pellets were ressuspended in Lysis Buffer (20 mM Tris-HCL pH7.5, 0.5M NaCl, 5 mM Imidazole with protease inhibitors) and sonicated 5x on ice in 30 s cycles (power 5- Sonicator XL2020, Misonix, Farmingdale, NY). The soluble fraction of the extracts was then incubated in TALON Metal Affinity Resin (Takara Bio Inc. , Japan), according to manufacturer's instructions. After several washes with Lysis Buffer, the resin coated with the protein was packed into a Poly-Prep Chromatography Column (Biorad, Hercules, CA). Proteins were eluted in the same buffer with 300 mM imidazole. For buffer exchange, purified UbcH10^wt^ and UbcH10^C114S^ proteins were dialyzed overnight, at 4°C, in a Slide-a-Lyzer 7 KDa Dialysis cassettes (Thermo Scientific, Waltham, MA). Final storage buffer was 20 mM Tris-HCL pH7.5, 0.3M NaCl). The purified proteins were concentrated in a Vivaspin 6 Centrifugal Concentrator MWCO 10.000 KDa (GE Healthcare, Issaquah, WA).

mRNA synthesis {#s4-4}
--------------

Barren^175TEV-^EGFP was cloned into a pRNA plasmid and mRNA was synthesized by in vitro transcription with the mMessage mMachine T3 kit (Ambion, Austin, TX), followed by purification with RNeasy kit (Qiagen, Germany), and elution in RNase-free water. To probe for the efficiency of Barren^TEV^ removal ([Figure 1C](#fig1){ref-type="fig"}), 0--30 min old embryos surviving only on Barren^TEV^-Myc were injected with Barren^TEV^-EGFP mRNA in pure water at \~2.2 μg/μl. Embryos were left to develop at 22°C for 1,5--2 hr, to allow for protein translation, before the subsequent injections.

In vitro cleavage experiments {#s4-5}
-----------------------------

Ovaries were dissected from females and homogenized in PBS. Extracts were sonicated for 2 min in a water-bath (power 5- Sonicator XL2020, Misonix). After centrifugation for 10 min at 15.000 rpm at 4°C, the supernatant was removed and adjusted to a final concentration of 2 μg/μl. For cleavage experiments, 80 μl of extract were incubated with 2 μg of TEV protease. At the indicated time points, 10 μl of the reaction were diluted with sample buffer, boiled and stored at −20°C.

Western-blot {#s4-6}
------------

Samples were loaded on a 10% SDS-gel for electrophoresis and transferred onto a membrane (Immun-Blot PVDF, Biorad). Western-blot analysis was performed according to standard protocols using the following antibodies: anti myc-tag (1:200, Santa Cruz Biotechnology, Dallas, TX, Cat\# sc-47694 RRID:[AB_627266](https://scicrunch.org/resolver/AB_627266)), anti-α-tubulin (1:50.000, DM1A, Sigma-Aldrich Cat\# T9026 RRID:[AB_477593](https://scicrunch.org/resolver/AB_477593)) and anti-Barren (1:3000, kindly provided by Hugo Bellen, ([@bib3]), RRID:[AB_2567044](https://scicrunch.org/resolver/AB_2567044)).

Microscopy {#s4-7}
----------

Aligned embryos on coverslips were covered with Series 700 halocarbon oil (Sigma-Aldrich). Imaging of embryos after mRNA injection ([Figure 1c](#fig1){ref-type="fig"}) was performed with a spinning disc Revolution XD microscope (Andor, UK) at 22°C. Stacks of around 20 frames 1 μm were taken at indicated times using a 100 × 1.4 oil immersion objective (Nikon, Japan) and iXon +512 EMCCD camera (Andor). Time-lapse microscopy was performed with an inverted wide-field DeltaVision microscope (Applied Precision Inc., Issaquah, WA) at 18--20°C in a temperature-controlled room. One stack of \~20 frames (0.8 μm apart) was acquired every 1 or 2 min using a 100 × 1.4 oil immersion objective (Olympus, Japan) and an EMCCD camera (Roper Cascade 1024, Roper Technologies, Inc., Sarasota, FL). Widefield images were restored by deconvolution with the Huygens v15.10/16.10 deconvolution software using a calculated point-spread function (RRID:[SCR_014237](https://scicrunch.org/resolver/SCR_014237), Scientific Volume Imaging, The Netherlands). Movies were assembled using FIJI software (RRID:[SCR_002285](https://scicrunch.org/resolver/SCR_002285)) ([@bib40]) and selected stills were processed with Photoshop CS6 (Adobe Systems Incorporated, San Jose, CA).

Quantitative imaging analysis {#s4-8}
-----------------------------

For the quantification of chromosome condensation presented in [Figure 3g](#fig3){ref-type="fig"} and [Figure 3---figure supplement 1](#fig3s1){ref-type="fig"}, deconvolved images were analyzed using Imaris v6.1 software (RRID:[SCR_007370](https://scicrunch.org/resolver/SCR_007370), Bitplane, Switzerland). The same metaphase was tracked over time and average values for mean voxel intensity, volume and surface area were normalized to the first frame after injection. For the fluorescence profiles presented in [Figures 3f](#fig3){ref-type="fig"} and [6b--e,a](#fig6){ref-type="fig"} wide 15 μm-long line was placed manually along the segregation plane and measured using the 'Plot Profile' function on FIJI software. For each data set, values were normalized to the maximum. Measurements of single chromatids width and length were performed on projected images (maximum intensity projection), using FIJI software and single chromatids mean voxel intensity measurements were performed using Imaris software. Quantification of chromosome movement ([Figure 4](#fig4){ref-type="fig"}) was performed as previously described ([@bib27]). Briefly, HisH2B-RFP was imaged at 1 min intervals. Images were segmented to select the chromosomal regions, based on an automatic threshold (set in the first frame after TEV injection), to create binary images. For each movie, a walking average of 3 frames was produced (using kymograph plug-in, written by J. Rietdorf and A. Seitz, EMBL, Heidelberg, Germany) creating a merged image in which the intensity is proportional to the overlap between consecutive frames. Intensity profiles were used to estimate the percentage of non-overlapping, 2- frame overlap and 3-frame overlap pixels. Graphic representation was performed using Prism seven software (RRID:[SCR_002798](https://scicrunch.org/resolver/SCR_002798), GraphPad, La Jolla, CA).

Statistical analysis {#s4-9}
--------------------

To compare the average of the centromere distances between each experimental condition ([Figure 6f](#fig6){ref-type="fig"}), at least 10 independent embryos were analyzed. Statistical analysis was performed using Prism seven software (RRID:[SCR_002798](https://scicrunch.org/resolver/SCR_002798)). Given that some datasets did not pass the normality test (D\'Agostino and Pearson normality test), multiple comparisons were performed using the non-parametric Krustal-Wallis test.
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In the interests of transparency, eLife includes the editorial decision letter and accompanying author responses. A lightly edited version of the letter sent to the authors after peer review is shown, indicating the most substantive concerns; minor comments are not usually included.

Thank you for submitting your article \"Metaphase chromosome structure is dynamically maintained by Condensin I-directed DNA (de)catenation\" for consideration by *eLife*. Your article has been favorably evaluated by Anna Akhmanova (Senior Editor) and three reviewers, one of whom is a member of our Board of Reviewing Editors. The following individual involved in review of your submission has agreed to reveal their identity: Luis Aragon (Reviewer \#2).

The reviewers have discussed the reviews with one another and the Reviewing Editor has drafted this decision to help you prepare a revised submission.

Three reviewers have assessed your manuscript, and the consensus opinion is that the experimental system is powerful; that the technical execution of the experiments was outstanding; and that the material is suitable for publication after revisions have been undertaken. Below, the overall view, comments and concerns are listed.

A number of studies have demonstrated the importance of condensin complexes for the structural organization and segregation of mitotic chromosomes, but the precise molecular function of these protein complexes has remained incompletely understood. Oliveira and colleagues report the effects of inactivating condensin I by TEV protease-mediated cleavage of the kleisin subunit at metaphase in *Drosophila* embryos. They observe that sister chromatids fail to resolve while centromeres stretch to the cell poles upon anaphase onset. Interestingly, the density of chromatin mass simultaneously increases in a Topo II-dependent manner, which suggests that sister chromatids that had been previously separated re-entangle in the absence of condensin function. This conclusion is supported by the facts that ([@bib2]) the density of already separated sister chromatids does not increase upon condensin cleavage and ([@bib1]) simultaneous inactivation of Topo II decreases the segregation defect caused by condensin cleavage. The authors conclude that condensin\'s role is to maintain sister separation beyond the initial condensation process by preventing re-catenation by Topo II.

Specific comments:

A\) The authors miss an opportunity to make their discussion and interpretation of their data as incisive and authoritative as it could be. They need to make it clear that the interpretation that hyper-compaction of chromosome arms is a consequence of increased catenation is a hypothesis; it is not directly demonstrated, only inferred. Furthermore, central to the biological relevance of the observations made is a precise definition of the term \'condensation\'. The authors here have a chance to clearly define \'condensation\' \[see below\] and compare it with \'compaction\' or \'over-compaction\' which is the phenotype measured in the imaging assays; and which does not necessarily reflect a specific \'structure\', determined by a specific mechanism. Does the intermingling of sister chromatids, which follows condensin inactivation, indeed reflect the same biological process that takes place during the folding of mitotic chromosomes during mitotic prophase? Presumably not. The statement that condensin removal leads to \'over-condensation\' of chromatids is terribly misleading if all that happens is that chromatids get intertwined \[\'...leads to \'over-compaction as a consequence of chromosome intertwining\' would work\]. Condensation \[the formation of an ordered (intra-chromatid) architecture that cannot just be achieved by compacting chromatin fibers in a random manner\] is actually precisely the opposite of what is being observed in this case. The conclusions that \"Topo II may alone drive chromosome condensation\" is hence a conceptual misinterpretation, as is would suggest that TopoII would either actively drive intra-chromatid catenation of that condensation is a self-organizing principle of mitotic chromatin and TopoII facilitated this process. In either case, only limited conclusions about the principles of the formation of mitotic chromosomes during prophase (i.e. the condensation mechanism) can be drawn from the intertwining of metaphase sister chromatids that results from condensin inactivation.

B\) It would be interesting to know whether when TopoII is depleted in metaphases arrested by SAC, if segregation is more defective than when TopoII is inactivated in metaphases obtained by UbcH10(C114S) (where SAC is not engaged). Yeast work (Farcas et al. 2011; Sen et al. 2016) has shown that plasmids contain higher levels of catenanes in nocodazole arrests than cdc20-depletion arrests, and that condensin activity is different in both arrest. Is this also the case here? The authors should comment on whether this experiment is technically feasible, whether they have this information, and whether they would consider it desirable to include this information and the result.

C\) Could one compare the levels of sister chromatid (re-)entangling after condensin inactivation in metaphase to the levels of intertwining before mitotic chromosomes start to form (i.e. after S phase). Perhaps the authors could measure histone H2Av-mRFP1 densities after TopoII inhibition in G2 phase cells and compare these values to the values measured after condensin activation during metaphase ([Figure 3G](#fig3){ref-type="fig"})? The authors might consider whether this would be a \'doable\' and informative experiment.

D\) Does TEV cleavage remove Barren also from centromeres? This is difficult to judge, since the CID-EGFP signal masks the Barren-TEV-EGFP signal in [Figure 1C](#fig1){ref-type="fig"}. It might be useful to show images without a labelled version of CID \[it would also be useful if the authors defined \'CID\' at its first use\].
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Author response

Specific comments:

A\) The authors miss an opportunity to make their discussion and interpretation of their data as incisive and authoritative as it could be. They need to make it clear that the interpretation that hyper-compaction of chromosome arms is a consequence of increased catenation is a hypothesis; it is not directly demonstrated, only inferred.

We have changed the text accordingly throughout the manuscript to present the results in a more direct and incisive manner. We additionally removed the consequential tone between the chromosome compaction observations and chromatid re-entanglement, and present the link between the two as a possibility. Although these two observations are likely to be connected, we agree it is not fully demonstrated. The Abstract was therefore considerably modified to highlight the major findings of the paper (chromatid-re-intertwining).

Furthermore, central to the biological relevance of the observations made is a precise definition of the term \'condensation\'. The authors here have a chance to clearly define \'condensation\' \[see below\] and compare it with \'compaction\' or \'over-compaction\' which is the phenotype measured in the imaging assays; and which does not necessarily reflect a specific \'structure\', determined by a specific mechanism. Does the intermingling of sister chromatids, which follows condensin inactivation, indeed reflect the same biological process that takes place during the folding of mitotic chromosomes during mitotic prophase? Presumably not. The statement that condensin removal leads to \'over-condensation\' of chromatids is terribly misleading if all that happens is that chromatids get intertwined \[\'...leads to \'over-compaction as a consequence of chromosome intertwining\' would work\]. Condensation \[the formation of an ordered (intra-chromatid) architecture that cannot just be achieved by compacting chromatin fibers in a random manner\] is actually precisely the opposite of what is being observed in this case. The conclusions that \"Topo II may alone drive chromosome condensation\" is hence a conceptual misinterpretation, as is would suggest that TopoII would either actively drive intra-chromatid catenation of that condensation is a self-organizing principle of mitotic chromatin and TopoII facilitated this process. In either case, only limited conclusions about the principles of the formation of mitotic chromosomes during prophase (i.e. the condensation mechanism) can be drawn from the intertwining of metaphase sister chromatids that results from condensin inactivation.

We thank the reviewers for pointing out this very important point. Indeed our experiments reveal mechanisms required for *maintenance* of chromosome architecture, which may or may not be similar to the process of chromosome condensation. We have changed the manuscript so that the term condensation is only used to refer to the normal process of mitotic chromosome assembly and used solely the term compaction to refer to the chromatin density we measure upon metaphase perturbations. We also defined specifically the term compaction. You can now read: "We defined chromosome compaction by degree of chromatin density, inferred from the signal of fluorescently labelled histone H2Av-mRFP1."

B\) It would be interesting to know whether when TopoII is depleted in metaphases arrested by SAC, if segregation is more defective than when TopoII is inactivated in metaphases obtained by UbcH10(C114S) (where SAC is not engaged). Yeast work (Farcas et al. 2011; Sen et al. 2016) has shown that plasmids contain higher levels of catenanes in nocodazole arrests than cdc20-depletion arrests, and that condensin activity is different in both arrest. Is this also the case here? The authors should comment on whether this experiment is technically feasible, whether they have this information, and whether they would consider it desirable to include this information and the result.

We agree that it would be very interesting to address the efficiency of DNA decatenation in a SAC-arrest situation, as the absence of spindle forces is likely to play a major role in this process. We have thus attempted to address this important issue by several means. However, several experimental limitations precluded a definitive answer. Below is a summary of our attempts to address the issue and the reasons why we considered these experiments inconclusive. A major technical limitation is the inability to measure the levels of catenation specifically in metaphase (a clear advantage of the referred studies in budding yeast, by the use of purifiable minichromosomes). Throughout the manuscript we used an alternative method, the efficiency of chromosome segregation during anaphase, as an indirect read-out for the amount of catenation. It is thus virtually impossible to access the catenation levels by this method in the absence of a functional spindle, as no anaphase takes place. We therefore opted for not including them in the manuscript.

1\) We have attempted to drive cells into anaphase upon SAC-arrest imposed by spindle depolymerization. This was achieved by colchicine arrest to depolymerize microtubules followed by a Mad2deltaC injection, which works as a dominant negative for the SAC arrest. This method was efficient in driving cells out of mitosis. However, in these experiments, chromosomes simply exited mitosis without any evident separation (formed a tetraploid nucleus), and it was thus impossible to estimate catenation levels under these conditions.

2\) We additionally attempted to use centromere separation in metaphase as an alternative measure of the amount of catenation. TEV-mediated cleavage of cohesin in embryos previously injected with colchicine resulted in a \~ 30% increase in the distances between sister-centromeres without full separation. The absence of full separation of sister chromatids could potentially be interpreted as a read-out of residual catenation, which would be sufficient to keep sister DNA molecules in proximity. However, ongoing studies in the lab revealed that chromatids that have been previously fully separated have a tendency to stay together upon disruption of the mitotic spindle. We therefore trust that the proximity between sister-chromatids observed upon cohesin cleavage is not a reliable read-out of the amount of DNA catenation as chromatids tend to "stick to each other" even when fully separated.

If the reviewers have any suggestions for an alternative experimental setup that could conclusively address this point we would be happy to consider it.

C\) Could one compare the levels of sister chromatid (re-)entangling after condensin inactivation in metaphase to the levels of intertwining before mitotic chromosomes start to form (i.e. after S phase). Perhaps the authors could measure histone H2Av-mRFP1 densities after TopoII inhibition in G2 phase cells and compare these values to the values measured after condensin activation during metaphase ([Figure 3G](#fig3){ref-type="fig"})? The authors might consider whether this would be a \'doable\' and informative experiment.

We have included this comparative analysis as a supplement to [Figure 6](#fig6){ref-type="fig"}. As expected, Topo II inhibition before mitotic entry leads to thick chromatin bridges. By contrast, inactivation in metaphase chromosomes produces a much milder phenotype, reinforcing that the degree of catenation in metaphase chromosomes is indeed residual. It was also interesting to note that the defects associated with condensin inactivation before mitosis were, by contrast, milder than observed upon condensin inactivation in metaphase-arrested chromosomes. This further supports the notion that TopoII dependent re-entanglement should be actively suppressed during metaphase, as the degree of re-entanglement in a prolonged metaphase may be even higher than the starting point.

D\) Does TEV cleavage remove Barren also from centromeres? This is difficult to judge, since the CID-EGFP signal masks the Barren-TEV-EGFP signal in [Figure 1C](#fig1){ref-type="fig"}. It might be useful to show images without a labelled version of CID \[it would also be useful if the authors defined \'CID\' at its first use\].

To address this point, we performed similar cleavage experiments in strains that do not express CID-GFP maker. This enables tracing Barren^TEV^-EGFP alone, confirming that after TEV injection Barren is rapidly removed from all chromosome regions, including centromeres. We replaced the previous figure with this new result ([Figure 1C](#fig1){ref-type="fig"}). We have also included a description of CID, as suggested (see subsection "A TEV-protease mediated system to inactivate condensin I in *Drosophila melanogaster*").

[^1]: ^\*^Reference number in our internal lab fly database.
